Page last updated: 2024-12-08

1-oxoisoindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

1-oxoisoindole isn't a commonly used name in chemistry. It's likely a synonym for a more familiar compound, **phthalimide**.

**Phthalimide (C8H5NO2)** is a white, crystalline solid with the following structure:

![Phthalimide Structure](https://upload.wikimedia.org/wikipedia/commons/thumb/9/93/Phthalimide-2D-skeletal.png/250px-Phthalimide-2D-skeletal.png)

Here's why phthalimide is important for research:

* **Versatile synthetic intermediate:** It serves as a key building block in the synthesis of various pharmaceuticals, agrochemicals, dyes, and polymers. It's used to introduce the phthalimide group into other molecules, which can then be further modified.
* **N-Haloamines:** Phthalimide can be reacted with halogens (like chlorine or bromine) to form N-haloamines. These compounds are important oxidizing agents used in organic chemistry.
* **Protective group:** Phthalimide can be used to protect amine groups during chemical reactions. This is because the phthalimide group is relatively inert to many reagents. The protected amine can be regenerated later in the synthesis.
* **Metal complexation:** Phthalimide can coordinate with metal ions, forming complexes with interesting properties. This has applications in areas like catalysis and material science.
* **Bioactivity:** Some phthalimide derivatives have shown biological activity, like anti-inflammatory, anti-cancer, and antifungal properties. This opens up opportunities for drug discovery.

**In summary, phthalimide is a versatile compound with various applications in research, particularly in organic synthesis, pharmaceuticals, and materials science.**

If you have more information about the context in which you encountered 1-oxoisoindole, I might be able to give you a more specific answer.

1-oxoisoindole: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID191109
CHEMBL ID352926
SCHEMBL ID113314
MeSH IDM0063494

Synonyms (13)

Synonym
1-oxoisoindole
bdbm50137366
1h-isoindol-1-one
CHEMBL352926 ,
isoindol-1-one
45738-06-5
isoindolone
AKOS006313837
SCHEMBL113314
XTBAPWCYTNCZTO-UHFFFAOYSA-N
1h-isoindolone
DTXSID80196612
FT-0734302
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Poly [ADP-ribose] polymerase 1 Mus musculus (house mouse)IC50 (µMol)30.00000.40000.42000.4400AID162567
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID162567Tested for inhibition of poly(ADP-ribose) polymerase-1 (PARP-1) in mouse using Cell protection assay2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).
AID162569Percent inhibition of poly(ADP-ribose) polymerase-1 (PARP-1) in mouse using Cell protection assay at 10 uM2004Bioorganic & medicinal chemistry letters, Jan-05, Volume: 14, Issue:1
The discovery and synthesis of novel adenosine substituted 2,3-dihydro-1H-isoindol-1-ones: potent inhibitors of poly(ADP-ribose) polymerase-1 (PARP-1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (32)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (6.25)18.2507
2000's5 (15.63)29.6817
2010's23 (71.88)24.3611
2020's2 (6.25)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (3.13%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other31 (96.88%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]